Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-09 | New | $24,998,919 | Unknown | Equity Only | SEC link | |
| 2021-01-05 | New | $37,199,807 | $37,199,807 | Equity Only | 06b | SEC link |
| 2020-01-27 | Amended | $20,000,003 | $5,026,248 | Equity Only | 06b | SEC link |
| 2019-10-04 | New | $14,973,755 | $14,973,755 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert J. Carpenter | Director |
| Peter Feinberg | Director |
| Diana F. Hausman | Director |
| Laurie B. Keating | Director |
| Joseph Kekst | Director |
| Andrew Phillips | Director |
| Thomas J. Schall | Director |
| Benjamin J. Zeskind | Director, Executive |